ESCC patients with NOTCH2 mutations had a significantly shortened OS in comparison to those without NOTCH2 mutations (p = 0.034, log-rank test, Supplementary Fig. 2d). This evidence concerns the gene NOTCH2 and esophageal squamous cell carcinoma.